During the production of F, as a result of the interaction of the beam of protons and secondary neutrons with the structural elements of the target body, many radionuclide impurities are created in the cyclotron. As part of this work, we theoretically predicted which isotopes would be activated in the target tantalum or silver bodies. Subsequently, we used gamma spectrometry analysis to verify these predictions. The results were compared with the work of other authors who studied titanium and niobium as materials for making the target body. Tantalum has been evaluated as the most favorable in terms of generating radionuclide impurities during the production of F by irradiation of O-enriched water in accelerated proton cyclotrons. Only three radionuclides were identified in the tested samples: W, Hf, and Ta with a half-life of fewer than 120 days. The remaining reactions led to the formation of stable isotopes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145432 | PMC |
http://dx.doi.org/10.3390/molecules28083485 | DOI Listing |
Pharmaceutics
November 2024
State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Zhivopisnaya Str., Bld. 46, 123098 Moscow, Russia.
Background: Radiochemical purity is a key criterion for the quality of radiopharmaceuticals used in clinical practice. The joint improvement of analytical methods capable of identifying related radiochemical impurities and determining the actual radiochemical purity, as well as the improvement of synthesis methods to minimize the formation of possible radiochemical impurities, is integral to the implementation of high-tech nuclear medicine procedures. PSMA-targeted radionuclide therapy with lutetium-177 has emerged as an effective treatment option for prostate cancer, and [Lu]Lu-PSMA-617 and [Lu]Lu-PSMA have achieved global recognition as viable radiopharmaceuticals.
View Article and Find Full Text PDFAppl Radiat Isot
December 2024
National Centre for Physics, Quaid-i-Azam University Campus Islamabad, Pakistan.
Cd (T = 6.5 h) and Cd (T = 461.9 d) are promising non-standard gamma-emitting radionuclides with significant potential for SPECT use.
View Article and Find Full Text PDFAppl Radiat Isot
December 2024
Radiation Physics Division, National Institute of Standards and Technology, 100 Bureau Dr., Gaithersburg, MD, 20899-8462, USA.
The massic activity of Ac in 0.1 mol/L HCl was measured by multiple primary methods over four consistent measurement campaigns. Results from the triple-to-double coincidence ratio (TDCR) method of liquid scintillation (LS) counting were in accord with other LS-based primary methods.
View Article and Find Full Text PDFAppl Radiat Isot
November 2024
Department of Applied Physics, Hawassa University, Hawassa, Ethiopia. Electronic address:
Theoretical investigations were carried out for the production of the medically important Zr radionuclide. This radionuclide is produced in the interaction of a proton projectile with Y-target, a readily available target with greater purity at ≈ 5-60 MeV. The Y (p, n)Zr production route, a promising avenue in the fields of medical imaging and radiopharmaceutical development, is of significant interest due to its potential to produce Zr, a radionuclide with a half-life of 78.
View Article and Find Full Text PDFInt J Nanomedicine
December 2024
King Abdullah Institute for Nanotechnology, King Saud University, Riyadh, 11451, Saudi Arabia.
Background: Researchers have shown substantial interest in bismuth oxide/reduced graphene oxide (BiO/RGO) nanocomposites due to their superior features that are not achievable by each material alone. The growing applications and manufacturing of BiO/RGO nanocomposites have raised concerns regarding their potential human health risks. This work was designed to explore the possible toxicity mechanisms of BiO/RGO nanocomposites in two distinct mammalian cell lines, normal rat kidney cells (NRK52E) and human liver cancer cells (HepG2).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!